JPY 2020.0
(0.65%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 6.65 Billion JPY | 14.22% |
2022 | 5.83 Billion JPY | 6.66% |
2021 | 5.46 Billion JPY | -4.28% |
2020 | 5.71 Billion JPY | -3.06% |
2019 | 5.89 Billion JPY | -0.28% |
2018 | 5.9 Billion JPY | 2.28% |
2017 | 5.77 Billion JPY | 6.32% |
2016 | 5.43 Billion JPY | 4.55% |
2015 | 5.19 Billion JPY | 11.68% |
2014 | 4.65 Billion JPY | 2.02% |
2013 | 4.56 Billion JPY | 1.92% |
2012 | 4.47 Billion JPY | 4.25% |
2011 | 4.29 Billion JPY | 10.19% |
2010 | 3.89 Billion JPY | 8.17% |
2009 | 3.6 Billion JPY | 3.55% |
2008 | 3.47 Billion JPY | 1.01% |
2007 | 3.44 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.68 Billion JPY | -1.14% |
2023 FY | 6.65 Billion JPY | 14.22% |
2023 Q1 | 1.64 Billion JPY | -1.2% |
2023 Q4 | 1.7 Billion JPY | 6.53% |
2023 Q3 | 1.6 Billion JPY | -5.87% |
2023 Q2 | 1.7 Billion JPY | 3.4% |
2022 Q1 | 1.39 Billion JPY | -0.23% |
2022 Q2 | 1.42 Billion JPY | 2.1% |
2022 Q3 | 1.34 Billion JPY | -5.87% |
2022 Q4 | 1.66 Billion JPY | 24.2% |
2022 FY | 5.83 Billion JPY | 6.66% |
2021 Q3 | 1.32 Billion JPY | -4.08% |
2021 FY | 5.46 Billion JPY | -4.28% |
2021 Q1 | 1.36 Billion JPY | -6.99% |
2021 Q2 | 1.37 Billion JPY | 1.11% |
2021 Q4 | 1.39 Billion JPY | 5.76% |
2020 Q3 | 1.34 Billion JPY | -9.58% |
2020 Q2 | 1.49 Billion JPY | 6.21% |
2020 Q1 | 1.4 Billion JPY | -5.61% |
2020 Q4 | 1.46 Billion JPY | 8.78% |
2020 FY | 5.71 Billion JPY | -3.06% |
2019 Q1 | 1.45 Billion JPY | -1.01% |
2019 Q2 | 1.5 Billion JPY | 3.64% |
2019 Q3 | 1.44 Billion JPY | -4.22% |
2019 FY | 5.89 Billion JPY | -0.28% |
2019 Q4 | 1.48 Billion JPY | 3.09% |
2018 Q3 | 1.43 Billion JPY | -4.74% |
2018 FY | 5.9 Billion JPY | 2.28% |
2018 Q1 | 1.49 Billion JPY | -0.77% |
2018 Q2 | 1.51 Billion JPY | 1.32% |
2018 Q4 | 1.46 Billion JPY | 2.08% |
2017 Q1 | 1.45 Billion JPY | -1.42% |
2017 Q3 | 1.38 Billion JPY | -3.82% |
2017 Q4 | 1.5 Billion JPY | 8.53% |
2017 Q2 | 1.43 Billion JPY | -0.8% |
2017 FY | 5.77 Billion JPY | 6.32% |
2016 FY | 5.43 Billion JPY | 4.55% |
2016 Q1 | 1.3 Billion JPY | -7.61% |
2016 Q2 | 1.34 Billion JPY | 2.98% |
2016 Q3 | 1.31 Billion JPY | -2.49% |
2016 Q4 | 1.47 Billion JPY | 12.25% |
2015 FY | 5.19 Billion JPY | 11.68% |
2015 Q4 | 1.41 Billion JPY | 16.53% |
2015 Q3 | 1.21 Billion JPY | -5.81% |
2015 Q2 | 1.28 Billion JPY | 0.35% |
2015 Q1 | 1.28 Billion JPY | 11.21% |
2014 FY | 4.65 Billion JPY | 2.02% |
2014 Q1 | 1.17 Billion JPY | 2.41% |
2014 Q3 | 1.14 Billion JPY | -2.07% |
2014 Q2 | 1.17 Billion JPY | -0.49% |
2014 Q4 | 1.15 Billion JPY | 0.48% |
2013 FY | 4.56 Billion JPY | 1.92% |
2013 Q3 | 1.1 Billion JPY | -4.04% |
2013 Q2 | 1.15 Billion JPY | 0.63% |
2013 Q4 | 1.15 Billion JPY | 3.84% |
2013 Q1 | 1.14 Billion JPY | 1.34% |
2012 Q2 | 1.11 Billion JPY | -1.2% |
2012 Q3 | 1.09 Billion JPY | -2.04% |
2012 Q4 | 1.13 Billion JPY | 3.46% |
2012 FY | 4.47 Billion JPY | 4.25% |
2012 Q1 | 1.13 Billion JPY | 2.73% |
2011 Q4 | 1.1 Billion JPY | 2.69% |
2011 FY | 4.29 Billion JPY | 10.19% |
2011 Q3 | 1.07 Billion JPY | -1.05% |
2011 Q2 | 1.08 Billion JPY | 4.53% |
2011 Q1 | 1.03 Billion JPY | 5.48% |
2010 Q1 | 990.98 Million JPY | 22.81% |
2010 Q4 | 982.47 Million JPY | 4.92% |
2010 FY | 3.89 Billion JPY | 8.17% |
2010 Q3 | 936.41 Million JPY | -4.99% |
2010 Q2 | 985.55 Million JPY | -0.55% |
2009 Q3 | 884.05 Million JPY | 0.0% |
2009 Q4 | 806.9 Million JPY | -8.73% |
2009 FY | 3.6 Billion JPY | 3.55% |
2008 Q2 | 903.09 Million JPY | 0.0% |
2008 Q3 | 882.65 Million JPY | -2.26% |
2008 Q4 | 780 Million JPY | -11.63% |
2008 FY | 3.47 Billion JPY | 1.01% |
2007 FY | 3.44 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Kitanotatsujin Corporation | 9.38 Billion JPY | 29.024% |
Euglena Co., Ltd. | 34.45 Billion JPY | 80.669% |
BEAUTY GARAGE Inc. | 5.8 Billion JPY | -14.818% |
Axas Holdings Co.,Ltd. | 3 Billion JPY | -121.959% |
C.I. Medical Co.,Ltd. | 9 Billion JPY | 26.052% |
Kao Corporation | 438.95 Billion JPY | 98.483% |
Rohto Pharmaceutical Co.,Ltd. | 117.23 Billion JPY | 94.319% |
Shiseido Company, Limited | 696.62 Billion JPY | 99.044% |
Lion Corporation | 160.09 Billion JPY | 95.84% |
Mandom Corporation | 29.51 Billion JPY | 77.432% |
Ivy Cosmetics Corporation | 1.72 Billion JPY | -285.989% |
Milbon Co., Ltd. | 24 Billion JPY | 72.251% |
Nippon Shikizai, Inc. | 2.31 Billion JPY | -188.082% |
Fancl Corporation | 61.61 Billion JPY | 89.192% |
KOSÉ Corporation | 189.85 Billion JPY | 96.492% |
Cota Co., Ltd. | 4.25 Billion JPY | -56.585% |
HABA Laboratories,Inc. | 8.21 Billion JPY | 18.92% |
C'bon Cosmetics Co.,Ltd. | 6.37 Billion JPY | -4.54% |
Pola Orbis Holdings Inc. | 119.68 Billion JPY | 94.436% |
Noevir Holdings Co., Ltd. | 31.54 Billion JPY | 78.885% |
Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -132.725% |
Almado, Inc. | 4.11 Billion JPY | -62.018% |
I-ne CO., LTD. | 17.86 Billion JPY | 62.722% |
Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | 58.275% |
Liberta Co.,Ltd. | 2.68 Billion JPY | -148.394% |
AXXZIA Inc. | 8.57 Billion JPY | 22.312% |
S.T. Corporation | 15.07 Billion JPY | 55.817% |
Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | 90.566% |
Earth Corporation | 57.25 Billion JPY | 88.368% |
Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -323.986% |
Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -412.896% |
Ya-Man Ltd. | 18.49 Billion JPY | 63.998% |
MTG Co., Ltd. | 33.26 Billion JPY | 79.978% |
TRANSACTION CO.,Ltd. | 4.57 Billion JPY | -45.522% |
SHOBIDO Corporation | 4.5 Billion JPY | -47.982% |
Artnature Inc. | 25.01 Billion JPY | 73.377% |
Pigeon Corporation | 34.72 Billion JPY | 80.823% |
Unicharm Corporation | 351.52 Billion JPY | 98.105% |
Paltac Corporation | 53.06 Billion JPY | 87.449% |
CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | 51.688% |